← Feed

MORTIMER IAN

SEC Form 4 insider
PRESIDENT & CEO · Xenon Pharmaceuticals Inc. ($XENE)
1 thesis · first seen Oct 1, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$XENESEC Form 4bullish
MORTIMER IAN · PRESIDENT & CEO at Xenon Pharmaceuticals Inc. · 3h agono track record yet
Long 30,000 shares of XENE
Bought 30,000 @ $37.38 avg · $1,121,400 · 2026-09-30

Form 4: MORTIMER IAN bought XENE

MORTIMER IAN (PRESIDENT & CEO at Xenon Pharmaceuticals Inc.) reported an open-market purchase of 30,000 shares of XENE at an average $37.38, roughly $1,121,400, in a Form 4 filed 2026-10-01.

Now $39.75as of Sep 18, 4:31 PM ET
View filing on SEC.gov →

End of results.